Abstract—
Phospholipases A2 (PLA2) are hydrolytic proteins, which cleave fatty acid off the second position (sn-2) of the phospholipid. An increased activity of PLA2 correlates with the course of many different inflammatory processes in the body. For the purpose of diagnosing and predicting pathological processes, systems for detecting the PLA2 activity are being developed. The key component of all test systems is a substrate of lipid or non-lipid nature, the breakdown of which by the enzyme leads to the appearance of analytical signal. Lipids as such do not absorb light in the visible region and do not fluoresce. Therefore, to determine the activity of PLA2, substrates with various labels are developed. Test systems for determination of the PLA2 activity can be divided into three groups, depending on the stage of the enzyme action a signal is formed at: (1) systems based on the detection of hydrolysis products; (2) systems based on the cleavage of fluorescently labeled substrates, and (3) systems based on the detection of membrane disintegration. Each of these groups has its own requirements for the structure of the substrate. This review is focused on the structure of PLA2 substrates used in systems to determine the enzyme activity; the proposed classification allows one to identify the strengths and weaknesses of existing detection systems and will be relevant when designing new test systems.
Similar content being viewed by others
REFERENCES
Dennis E.A., Cao J., Hsu Y.-H., Magrioti V., Kokotos G. 2011. Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev.111 (10), 6130–6185. https://doi.org/10.1021/cr200085w
Vasquez A. M., Mouchlis V.D., Dennis E.A. 2018. Review of four major distinct types of human phospholipase A2. Adv. Biol. Regul.67 (3), 212–218. https://doi.org/10.1016/j.jbior.2017.10.009
Sofogianni A., Alkagiet S., Tziomalos K. 2018. Lipoprotein-associated phospholipase A2 and coronary heart disease. Curr. Pharm. Des.24 (3), 291–296. https://doi.org/10.2174/1381612824666180111110550
Talmud P.J., Holmes M.V. 2015. Deciphering the causal role of sPLA2s and Lp-PLA2 in coronary heart disease. Arterioscler. Thromb. Vasc. Biol.35 (11), 2281–2289. https://doi.org/10.1161/ATVBAHA.115.305234
Dore E., Boilard E. 2019. Roles of secreted phospholipase A 2 group IIA in inflammation and host defense. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids.1864 (6), 789–802. https://doi.org/10.1016/j.bbalip.2018.08.017
Nikolaou A., Kokotou M.G., Vasilakaki S., Kokotos G. 2019. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids.1864 (6), 941–956. https://doi.org/10.1016/j.bbalip.2018.08.009
Zambelli V.O., Picolo G., Fernandes C.A.H., Fontes M.R.M., Cury Y. 2017. Secreted phospholipases A2 from animal venoms in pain and analgesia. Toxins.9 (12), 406. https://doi.org/10.3390/toxins9120406
Scott D., White S., Otwinowski Z., Yuan W., Gelb M., Sigler P. 1990. Interfacial catalysis: The mechanism of phospholipase A2. Science.250 (4987), 1541–1546. https://doi.org/10.1126/science.2274785
Winget J.M., Pan Y.H., Bahnson B.J. 2006. The interfacial binding surface of phospholipase A2s. Biochim. Biophys. Acta.1761 (11), 1260–1269. https://doi.org/10.1016/j.bbalip.2006.08.002
Berg O.G., Gelb M.H., Tsai M.-D., Jain M.K. 2001. Interfacial enzymology: The secreted phospholipase A2-paradigm. Chem. Rev.101 (9), 2613–2654. https://doi.org/10.1021/cr990139w
Nevalainen T.J., Eerola L.I., Rintala E., Laine V.J., Lambeau G., Gelb M.H. 2005. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids.1733 (2–3), 210–223. https://doi.org/10.1016/j.bbalip.2004.12.012
Macdonald D.J., Boyle R. M., Glen A.C.A., Leslie C.C., Glen A.I.M., Horrobin D.F. 2015. The development of an ELISA for group IVA phospholipase A2 in human red blood cells. Prostaglandins, Leukotrienes and Essential Fatty Acids.94, 43–48. https://doi.org/10.1016/j.plefa.2014.11.003
Topbas C., Swick A., Razavi M., Anderson N.L., Pearson T.W., Bystrom C. 2018. Measurement of lipoprotein-associated phospholipase A2 by use of 3 different methods: Exploration of discordance between ELISA and activity assays. Clin. Chem.64 (4), 697–704. https://doi.org/10.1373/clinchem.2017.279752
Zhuo S., Wolfert R.L., Yuan C. 2017. Biochemical differences in the mass and activity tests of lipoprotein-associated phospholipase A 2 explain the discordance in results between the two assay methods. Clin. Biochem.50 (18), 1209–1215. https://doi.org/10.1016/j.clinbiochem.2017.08.019
Šribar J., Križaj I. 2011. Secreted phospholipases A2 – Not just enzymes. Acta Chimica Slovenica.58 (4), 678–688.
Donato L.J., Meeusen J. W., Callanan H., Saenger A.K., Jaffe A. S. 2016. Advantages of the lipoprotein-associated phospholipase A2 activity assay. Clin. Biochem. 49 (1–2), 172–175. https://doi.org/10.1016/j.clinbiochem.2015.09.002
Ong W.Y., Farooqui T., Kokotos G., Farooqui A.A. 2015. Synthetic and natural inhibitors of phospholipases A2: Their importance for understanding and treatment of neurological disorders. ACS Chem. Neurosci. 6 (6), 814–831. https://doi.org/10.1021/acschemneuro.5b00073
Vaskovsky V.E., Kostetsky E.Y., Vasendin I.M. 1975. A universal reagent for phospholipid analysis. J. Chromatography A.114 (1), 129–141. https://doi.org/10.1016/S0021-9673(00)85249-8
Alekseeva A.S., Tretiakova D.S., Chernikov V.P., Utkin Y.N., Molotkovsky J.G., Vodovozova E.L., Boldyrev I.A. 2017. Heterodimeric V. nikolskii phospholipases A2 induce aggregation of the lipid bilayer. Toxicon.133, 169–179. https://doi.org/10.1016/j.toxicon.2017.05.015
chebb N.H., Falck D., Faber H., Hein E.-M., Karst U., Hayen H. 2009. Fast method for monitoring phospholipase A2 activity by liquid chromatography–electrospray ionization mass spectrometry. J. Chromatography A. 1216 (27), 5249–5255. 10.1016/j.chroma.2009.05.02
Stephenson D.J., MacKnight H.P., Hoeferlin L.A., Park M.A., Allegood J.C., Cardona C.L., Chalfant C.E. 2019. A rapid and adaptable lipidomics method for quantitative UPLC-mass spectrometric analysis of phosphatidylethanolamine and phosphatidylcholine in vitro, and in cells. Anal. Methods.11 (13), 1765–1776. https://doi.org/10.1039/C9AY00052F
Tan G., Tian Y., Addy M., Cheng Y., Xie Q., Zhang B., Liu Y., Chen P., Ruan R. 2017. Structural analysis of phosphatidylcholine using a thin layer chromatography-based method. Eur. J. Lipid Sci. Technol.119 (7), 1600282. https://doi.org/10.1002/ejlt.201600282
Leslie C.C., Gelb M.H. 2004. Assaying phospholipase A2 activity. Methods Mol. Biol. (Clifton, N.J.).284, 229–242.
Petrovic N., Grove C., Langton P.E., Misso N.L.A., Thompson P.J. 2001. A simple assay for a human serum phospholipase A2 that is associated with high-density lipoproteins. J. Lipid Research.42 (10), 1706–1713.
Eba C., Okano A., Nakano H., Iwasaki Y. 2014. A chromogenic substrate for solid-phase detection of phospholipase A2. Analyt. Biochem.447 (1), 43–45. https://doi.org/10.1016/j.ab.2013.11.007
Cerelli M.J., Grimm K., Duan X., Mulberg E., Jalilie M., Sekella P., Payes M., Cox H., Blick K.E., Fang K.C., Zychlinsky E. 2016. Evaluation of recombinant enzyme calibration to harmonize lipoprotein-associated phospholipase A 2 activity results between instruments. Clin. Biochem. 49 (6), 480–485. https://doi.org/10.1016/j.clinbiochem.2015.11.018
Alekseeva A.S., Korotaeva A.A., Samoilova E.V., Volynsky P.E., Vodovozova E.L., Boldyrev I.A. 2014. Secretory phospholipase A2 activity in blood serum: The challenge to sense. Biochem. Biophys. Res. Commun.454 (1), 178–182. https://doi.org/10.1016/j.bbrc.2014.10.069
Benson M.A., Schmalzer K.M., Frank D.W. 2010. A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA2 activity. Clinica Chimica Acta.411 (3–4), 190–197. https://doi.org/10.1016/j.cca.2009.10.025
Currò M., Ferlazzo N., Risitano R., Condello S., Vecchio M., Caccamo D., Ientile, R. 2014. Transglutaminase 2 and phospholipase A2 interactions in the inflammatory response in human Thp-1 monocytes. Amino Acids.46 (3), 759–766. https://doi.org/10.1007/s00726-013-1569-y
Machado-Aranda D., Wang Z., Yu B., Suresh M.V., Notter R.H., Raghavendran K. 2013. Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice. Surgery.153 (1), 25–35. https://doi.org/10.1016/j.surg.2012.05.043
Abe A., Rzepecki P.W., Shayman J.A. 2013. A fluorogenic phospholipid for the detection of lysosomal phospholipase A2 activity. Analyt. Biochem.434 (1), 78–83. https://doi.org/10.1016/j.ab.2012.11.004
Wichmann O., Gelb M.H., Schultz C. 2007. Probing phospholipase A2 with fluorescent phospholipid substrates. ChemBioChem.8 (13), 1555–1569. https://doi.org/10.1002/cbic.200600462
Popov A.V., Mawn T.M., Kim S., Zheng G., Delikatny E.J. 2010. Design and synthesis of phospholipase C and A 2 -activatable near-infrared fluorescent smart probes. Bioconjug. Chem.21 (10), 1724–1727. https://doi.org/10.1021/bc100271v
Maity G., Bhattacharyya D. 2005. Assay of snake venom phospholipase A2 using scattering mode of a spectrofluorimeter. Curr. Sci.89 (6), 1004–1008.
Horton K.L., Stewart K.M., Fonseca S.B., Guo Q., Kelley S.O. 2008. Mitochondria-penetrating peptides. Chem. Biol.15 (4), 375–382. https://doi.org/10.1016/j.chembiol.2008.03.015
Liu Y., Cheng D., Lin I.-H., Abbott N.L., Jiang H. 2012. Microfluidic sensing devices employing in situ-formed liquid crystal thin film for detection of biochemical interactions. Lab on a Chip.12 (19), 3746–3753. https://doi.org/10.1039/c2lc40462a
Huang C., Zhou L., Liu Y., Lai L. 2006. A continuous fluorescence assay for phospholipase A2 with nontagged lipid. Analyt. Biochem.351 (1), 11–17. https://doi.org/10.1016/j.ab.2006.01.021
Radvanyi F., Jordan L., Russo-Marie F., Bon C. 1989. A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Analyt. Biochem. 177 (1), 103–109. https://doi.org/10.1016/0003-2697(89)90022-5
Mallat Z., Steg P.G., Benessiano J., Tanguy M.L., Fox K.A., Collet J.P., Dabbous O.H., Henry P., Carruthers K.F., Dauphin A., Arguelles C.S., Masliah J., Hugel B., Montalescot G., Freyssinet J., Asselain B., Tedgui A. 2005. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. J. Am. Coll. Cardiol.46 (7), 1249–1257. https://doi.org/10.1016/j.jacc.2005.06.056
Mallat Z., Benessiano J., Simon T., Ederhy S., Sebella-Arguelles C., Cohen A., Huart V., Wareham N., Luben R., Khaw K., Tedgui A., Boekholdt M. 2007. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: The EPIC-NORFOLK study. Arteriosclerosis, Thrombosis and Vascular Biology. 27 (5), 1177–1183. https://doi.org/10.1161/ATVBAHA.107.139352
Tabaei S.R., Rabe M., Zetterberg H., Zhdanov V.P., Höök F. 2013. single lipid vesicle assay for characterizing single-enzyme kinetics of phospholipid hydrolysis in a complex biological fluid. J. Amer. Chem. Soc.135 (38), 14151–14158. https://doi.org/10.1021/ja4046313
Alekseeva A.S., Tretiakova D.S., Melnikova D.N., Molotkovsky U.G., Boldyrev I.A. 2016. Novel fluorescent membrane probe 2,3;5,6-bis(cyclohexyl)-BODIPY-labeled phosphatidylcholine. Russ. J. Bioorgan. Chem.42 (3), 305–309. https://doi.org/10.1134/S1068162016030031
Tretiakova D.S., Alekseeva A.S., Galimzyanov T.R., Boldyrev A.M., Chernyadyev A.Y., Ermakov Y.A., Batishchev O.V., Vodovozova E.L., Boldyrev I.A. 2018. Lateral stress profile and fluorescent lipid probes. FRET pair of probes that introduces minimal distortions into lipid packing. Biochim. Biophys. Acta, Biomembr.1860 (11), 2337–2347. https://doi.org/10.1016/j.bbamem.2018.05.020
Tretiakova D., Onishchenko N., Boldyrev I., Mikhalyov I., Tuzikov A., Bovin N., Evtushenko E., Vodovozova E. 2018. Influence of stabilizing components on the integrity of antitumor liposomes loaded with lipophilic prodrug in the bilayer. Colloids Surf. B, Biointerfaces.166, 45–53. https://doi.org/10.1016/j.colsurfb.2018.02.061
Liu X.-Y., Nakamura C., Yang Q., Miyake J. 2001. Phospholipase A2-catalyzed membrane leakage studied by immobilized liposome chromatography with online fluorescent detection. Analyt. Biochemistry.293 (2), 251–257. https://doi.org/10.1006/abio.2001.5136
Liu X.-Y., Nakamura C., Hasegawa M., Miyake J. 2003. Effect of lipid composition on phospholipase A2-catalyzed membrane leakage in immobilized liposomes: Sensitization for polychlorinated biphenyls detection with antibody affinity column tandem with fluorescent liposome column. Electrophoresis.24 (18), 3165–3171. https://doi.org/10.1002/elps.200305530
Liu X.-Y., Nakamura C., Nakamura N., Hirano T., Shinbo T., Miyake J. 2005. Detection of polychlorinated biphenyls using an antibody column in tandem with a fluorescent liposome column. J. Chromatography A.1087 (1–2), 229–235. https://doi.org/10.1016/j.chroma.2005.03.013
Chen H., Lim S.K., Chen P., Huang J., Wang Y., Palaniappan A., Platt M., Leidberg B., Tok A. 2015. Reporter-encapsulated liposomes on graphene field effect transistors for signal enhanced detection of physiological enzymes. Phys. Chem. Chem. Phys.17 (5), 3451–3456. https://doi.org/10.1039/C4CP04644G
Li J., Zhang Y., Ai J., Gao Q., Qi H., Zhang C., Cheng Z. 2016. Quantum dot cluster (QDC)-loaded phospholipid micelles as a FRET probe for phospholipase A2 detection. RSC Advances.6 (19), 15 895–15 899. https://doi.org/10.1039/C5RA25292J
Chen S.-H., Hsu Y.-P., Lu H.-Y., Ho J.A. 2014. Gold/Phospholipid nanoconstructs as label-free optical probes for evaluating phospholipase A2 activity. Biosensors and Bioelectronics.52, 202–208. https://doi.org/10.1016/j.bios.2013.08.017
Guo C., Zhang Y., Li Y., Xu S., Wang L. 2019. 19F MRI nanoprobes for the turn-on detection of phospholipase A2 with a low background. Analyt. Chem.91 (13), 8147–8153. https://doi.org/10.1021/acs.analchem.9b00435
ACKNOWLEDGMENTS
The work was supported by the Russian Science Foundation (project no. 19-75-00101).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interests.
This article does not contain any studies involving animals or human participants performed by any of the authors.
Additional information
Translated by E. Makeeva
Rights and permissions
About this article
Cite this article
Alekseeva, A.S., Boldyrev, I.A. Phospholipase A2. Methods for Activity Monitoring. Biochem. Moscow Suppl. Ser. A 14, 267–278 (2020). https://doi.org/10.1134/S1990747820040030
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990747820040030